Review of Peptide Growth Factors in Benign Prostatic Hyperplasia and Urological Malignancy (1995)

No AccessJournal of UrologyClinical Urology: Review Article1 Apr 1995Review of Peptide Growth Factors in Benign Prostatic Hyperplasia and Urological Malignancy Mitchell S. Steiner Mitchell S. SteinerMitchell S. Steiner View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)67516-5AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail References 1 : Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature1986; 319: 230. Google Scholar 2 : The transforming growth factor-beta family. Ann. Rev. Cell Biol.1990; 6: 597. Google Scholar 3 : Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J.1992; 6: 3362. Google Scholar 4 : Epidermal growth factor. Ann. Rev. Biochem.1979; 48: 193. Google Scholar 5 : Transforming growth factor-alpha. A model for membrane-anchored growth factors. J. Biol. Chem.1990; 265: 21393. Google Scholar 6 : Epidermal growth factor. J. Biol. Chem.1990; 265: 7709. Google Scholar 7 : Expression of the transforming growth factor-alpha gene in tumor cells and normal tissue. Cancer Cells1989; 7: 297. Google Scholar 8 : The heparin-binding (fibroblast) growth factor family of proteins. Ann. Rev. Biochem.1989; 58: 575. Google Scholar 9 : Fibroblast growth factor and its involvement in developmental processes. Curr. Top. Dev. Biol.1990; 24: 57. Google Scholar 10 : Human basic fibroblast growth factor: nucleotide sequence and genomic organization. EMBO J.1986; 5: 2523. Google Scholar 11 : Structural characterization and biological functions of fibroblast growth factor. Endocrine Rev.1987; 8: 95. Google Scholar 12 : Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken choriollantoic membrane. J. Cell Biol.1990; 111: 731. Google Scholar 13 : Keratinocyte growth factor (KGF) modifies the response of prostatic epithelial cells to stimulatory and inhibitory factors. Soc. Basic Urol. Res.1993; 7: 3. abstract. Google Scholar 14 : Growth factors and cancer. Science1991; 254: 1146. Google Scholar 15 : Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate1993; 22: 243. Google Scholar 16 : Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells. J. Clin. Endocr. Metab.1991; 73: 401. Google Scholar 17 : Stimulation of bone matrix apposition in vitro by local growth factors: a comparison between insulin-like growth factor I, platelet-derived growth factor, and transforming growth factor beta. Endocrinology1990; 127: 69. Google Scholar 18 : Transforming growth factor-beta stimulates production of insulin-like growth factor-binding protein-3 by human skin fibroblasts. Endocrinology1991; 128: 1425. Google Scholar 19 : Potential role of HBGF (FGF) and TGF-beta on prostate growth, Adv. Exp. Med. Biol.1992; 324: 107. Google Scholar 20 : Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J. Cell Biol.1991; 115: 1091. Google Scholar 21 : TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell1990; 63: 245. Google Scholar 22 : Transforming growth factor-beta and its actions on cellular growth and differentiation. Curr. Top. Dev. Biol.1990; 24: 95. Google Scholar 23 : Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J. Cell Biol.1988; 106: 1659. Google Scholar 24 : A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. Proc. Natl. Acad. Sci.1990; 87: 1486. Google Scholar 25 : Modulation of the immune response by transforming growth factor beta. Int. Arch. Allergy Appl. Immunol.1992; 99: 1. Google Scholar 26 : Role of peptide growth factors in the prostate: a review. Urology1993; 42: 99. Google Scholar 27 : Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog. J. Clin. Endocr. Metab.1991; 72: 740. Google Scholar 28 : Inhibition of IGF-II-stimulated growth of prostate cancer cells by IGF-I receptor-specific monoclonal antibody and antisense oligonucleotide of IGF-II messenger RNA. J. Urol.1994; 151: 367A. part 2, abstract 560. Google Scholar 29 : Immunocytochemical localization of human epidermal growth factor/urogastrone in several human tissues. J. Histochem. Cytochem.1985; 33: 315. Google Scholar 30 : Prostatic epidermal growth factor receptors and their regulation by androgens. Endocrinology1987; 121: 1461. Google Scholar 31 : Androgenic regulation of epidermal growth factor in the mouse ventral prostate. Biochem. Int.1988; 17: 311. Google Scholar 32 : Epidermal growth factor and prostatic carcinoma: an immunohistochemical study. J. Urol.1988; 139: 857. Link, Google Scholar 33 : Androgens modulate epidermal growth factor receptor levels in the rat ventral prostate. Mol. Cell. Endocr.1988; 56: 21. Google Scholar 34 : Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J. Urol.1990; 143: 1272. Link, Google Scholar 35 : Urogastrone-epidermal growth factor concentrations in prostatic fluid of normal individuals and patients with benign prostatic hypertrophy. Clin. Sci.1986; 70: 359. Google Scholar 36 : Androgens and transforming growth factor beta modulate the growth response to epidermal growth factor in human prostatic tumor cells (LNCaP). Mol. Cell. Endocr.1988; 60: 101. Google Scholar 37 : Different hormonal requirements for androgen-independent growth of normal and tumor epithelial cells from rat prostate. In Vitro Cell. Dev. Biol.1987; 23: 147. Google Scholar 38 : Transforming growth factor-alpha and its receptor are expressed in the epithelium of the rat prostate gland. Endocrinology1993; 133: 1306. Google Scholar 39 : Heparin-binding growth factor/prostatropin attenuates inhibition of rat prostate tumor epithelial cell growth by transforming growth factor type beta. In Vitro Cell Dev. Biol.1988; 24: 243. Google Scholar 40 : Heparin-binding growth factor isolated from human prostatic extracts. Prostate1988; 12: 343. Google Scholar 41 : Characterization of growth factors derived from the rat ventral prostate. J. Urol.1988; 139: 1106. Link, Google Scholar 42 : Evidence for an organ- and sex-specific role of basic fibroblast growth factor in the development of the fetal mammalian reproductive tract. Endocrinology1991; 129: 2148. Google Scholar 43 : Cultured human prostate-derived fibroblasts produce a factor that stimulates their growth with properties indistinguishable from basic fibroblast growth factor. Prostate1989; 15: 355. Google Scholar 44 : Increased expression of genes for basic fibroblast growth factor and transforming growth factor type beta 2 in human benign prostatic hyperplasia. Prostate1990; 16: 71. Google Scholar 45 : A form of basic fibroblast growth factor is secreted into the adluminal fluid of the rat coagulating gland. Prostate1989; 14: 353. Google Scholar 46 : Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors. Cancer Res.1989; 49: 2485. Google Scholar 47 : Expression of basic fibroblast growth factor mRNA in benign prostatic hyperplasia and prostatic carcinoma. Prostate1988; 13: 241. Google Scholar 48 : Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J. Cell. Physiol.1990; 144: 326. Google Scholar 49 : A keratinocyte growth factor receptor-derived peptide antagonist identifies part of the ligand binding site. J. Biol. Chem.1993; 268: 9180. Google Scholar 50 : Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture. Cancer Res.1984; 44: 1998. Google Scholar 51 : Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res.1987; 47: 707. Google Scholar 52 : Human transforming growth factor type beta 2: production by a prostatic adenocarcinoma cell line, purification, and initial characterization. Biochemistry1987; 26: 2406. Google Scholar 53 : Differential effects of transforming growth factor beta on human prostate cancer cells in vitro. Mol. Cell. Endocr.1989; 62: 79. Google Scholar 54 : Production and significance of TGF-beta in AT-3 metastatic cell line established from the Dunning rat prostatic adenocarcinoma. Biochem. Biophys. Res. Comm.1990; 166: 840. Google Scholar 55 : Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death. Mol. Endocr.1989; 3: 1515. Google Scholar 56 : Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol. Endocr.1992; 6: 15. Google Scholar 57 : Isolation of a prostate carcinoma cell proliferation-inhibiting factor from human seminal plasma and its similarity to transforming growth factor beta. Cancer Res.1992; 52: 5821. Google Scholar 58 : Normal and abnormal development of the male urogenital tract: role of androgens, mesenchymal-epithelial interactions, and growth factors. J. Androl.1992; 13: 465. Google Scholar 59 : Interaction of epidermal growth factor and transforming growth factor beta in human prostatic epithelial cells in culture. Prostate1992; 21: 133. Google Scholar 60 : The partial dependency of human prostatic growth factor on steroid hormones in stimulating thymidine incorporation into DNA. J. Urol.1987; 138: 909. Link, Google Scholar 61 : Gene activity during the early phase of androgen-stimulated rat prostate regrowth. Cancer Res.1989; 49: 5889. Google Scholar 62 : The prostate gland: morphology and pathology. Monogr. Urol.1983; 4: 3. Google Scholar 63 : The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J.1990; 9: 907. Google Scholar 64 : The mouse int-2 gene exhibits basic fibroblast growth factor activity in a basic fibroblast growth factor-responsive cell line. Cell Growth Differ.1990; 1: 463. Google Scholar 65 : Benign prostatic hyperplasia in a transgenic mouse: a new hormonally sensitive investigatory model. J. Urol.1993; 149: 633. Link, Google Scholar 66 : Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science1989; 245: 752. Google Scholar 67 : Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors. J. Biol. Chem.1990; 265: 12767. Google Scholar 68 : Influence of transforming growth factor beta 1 and other growth factors on basic fibroblast growth factor level and proliferation of cultured human prostate-derived fibroblasts. Prostate1993; 22: 183. Google Scholar 69 : Production of epidermal growth factor and transforming growth factor-alpha by the androgen-responsive LNCaP human prostate cancer cell line. Prostate1990; 16: 209. Google Scholar 70 : Effects of sex hormone binding globulin (SHBG) on human prostatic carcinoma. J. Steroid Biochem. Molec. Biol.1991; 40: 833. Google Scholar 71 : Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)/TGF-alpha receptor. J. Clin. Endocr. Metab.1993; 77: 1472. Google Scholar 72 : Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha. Cancer Res.1991; 51: 2780. Google Scholar 73 : Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues. J. Urol.1993; 149: 170. Link, Google Scholar 74 : p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate. J. Urol.1992; 147: 496. Link, Google Scholar 75 : Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature1988; 331: 173. Google Scholar 76 : Transformation of mouse BALB/c 3T3 cells with human basic fibroblast growth factor cDNA. Mol. Cell. Biol.1988; 8: 588. Google Scholar 77 : Basic fibroblast growth factor in human prostate cancer cells. Cancer Res.1992; 52: 571. Google Scholar 78 : Localization of basic fibroblast growth factor (bFGF) in a metastatic cell line (AT-3) established from the Dunning prostatic carcinoma of rat: application of a specific monoclonal antibody. Adv. Exp. Med. Biol.1992; 324: 131. Google Scholar 79 : IGF-I and IGF-binding proteins: stimulatory and inhibitory factors secreted by human prostatic adenocarcinoma cells. Growth Factors1991; 4: 231. Google Scholar 80 : Constitutive expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor abrogates all requirements for exogenous growth factors. Cell Growth Diff.1992; 3: 199. Google Scholar 81 : Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1. Cancer Res.1993; 53: 1102. Google Scholar 82 : Activation of androgen receptor mediated transcription by insulin-like growth factor-1 in prostatic tumour cell lines. J. Urol.1994; 151: 460A. part 2, abstract 923. Google Scholar 83 : Transforming growth factor beta 1 as a biomarker for prostate cancer. J. Cell. Biochem.1992; 16H: 54. Google Scholar 84 : Expression of transforming growths (TGF-alpha and TGF-beta) and epidermal growth factor (EGF) in normal and malignant rat prostate. J. Urol.1990; 143: 240A. part 2, abstract 208. Google Scholar 85 : Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression. Mol. Endocr.1991; 5: 503. Google Scholar 86 : Mutation of the retinoblastoma suseptibility protein correlates with resistance to TGF beta inhibition in prostate cancer. Proc. Amer. Ass. Cancer Res.1994; 35: 127. abstract. Google Scholar 87 : Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study. Hum. Path.1993; 24: 4. Google Scholar 88 : Modulation of transforming growth factor beta 1 action growth factors and extracellular matrix. Proc. Amer. Ass. Cancer Res.1994; 35: 36. abstract. Google Scholar 89 : Potential role of T-lymphocytes in prostate tumor growth enhancement by transforming growth factor beta1 (TGF beta 1). J. Urol.1994; 151: 366A. part 2, abstract 554. Google Scholar 90 : Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem.1986; 261: 4337. Google Scholar 91 : Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. Natl. Acad. Sci.1990; 87: 7678. Google Scholar 92 : Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells. Exp. Cell Res.1993; 207: 1. Google Scholar 93 : Hormonal regulation of transforming growth factor beta-2 expression in human prostate cancer. J. Steroid Biochem. Molec. Biol.1993; 47: 137. Google Scholar 94 : Differential expression of transforming growth factor-beta 1 and beta 3 as well as c-fos mRNA in normal human prostate, benign prostatic hyperplasia and prostatic cancer. World J. Urol.1994; 12: 96. Google Scholar 95 : Inhibitory effects of the bone-derived growth factors osteoinductive factor and transforming growth factor-beta on isolated osteoclasts. Endocrinology1990; 126: 3069. Google Scholar 96 : Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J. Cell Biol.1990; 110: 2195. Google Scholar 97 : Biosynthesis and in vivo localization of the decapentaplegic-Vg-related protein, DVR-6 (bone morphogenetic protein-6). J. Cell Biol.1993; 120: 493. Google Scholar 98 : Expression of bone morphogenetic protein-6 (BMP-6) in normal rat prostate and in the Dunning rat prostate adenocarcinoma model. Soc. Basic Urol. Res.1994; 8: 52. abstract. Google Scholar 99 : Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine. J. Urol.1993; 150: 1126. Link, Google Scholar 100 : Transforming growth factor type beta in normal human urine. Biochem. Biophys. Res. Comm.1987; 148: 1503. Google Scholar 101 : Epidermal growth factor in the normal and neoplastic kidney and bladder. J. Urol.1988; 139: 170. Link, Google Scholar 102 : Characterization and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumors. Cancer Res.1989; 49: 5810. Google Scholar 103 : Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J. Natl. Cancer Inst.1993; 85: 241. Google Scholar 104 : Loss of KGF receptor expression in aggressive transitional cell carcinoma (TCC) of the bladder. J. Urol.1994; 151: 350A. part 2, abstract 490. Google Scholar 105 : The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer1990; 65: 1619. Google Scholar 106 : Urine from patients with transitional-cell carcinoma stimulates migration of capillary endothelial cells. New Engl. J. Med.1981; 305: 869. Google Scholar 107 : Acidic fibroblast growth factor is a modulator of epithelial plasticity in a rat bladder carcinoma cell line. Proc. Natl. Acad. Sci.1990; 87: 1124. Google Scholar 108 : Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential. Proc. Natl. Acad. Sci.1991; 88: 2893. Google Scholar 109 : Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the human bladder. Ann Surg.1980; 192: 762. Google Scholar 110 : Loss of TGF-beta 1 induced exfoliation, repression of c-myc and cytostasis in vitro in bladder tumor cells from carcinogen-treated F344 rats. Proc. Amer. Ass. Cancer Res.1994; 35: 164. abstract. Google Scholar 111 : Growth factors in urologic tissues: detection, characterization, and clinical applications. Urology1992; 40: 491. Google Scholar 112 : Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue. Cancer Res.1989; 49: 3407. Google Scholar 113 : Origin of urinary epidermal growth factor in humans: excretion of endogenous EGF and infused [sup 131 I]-human EGF and kidney histochemistry. Clin. Exp. Pharmacol. Physiol.1992; 19: 667. Google Scholar 114 : Growth factors and kidney development. Ped. Nephrol.1993; 7: 616. Google Scholar 115 : Epidermal growth factor receptor gene analysis in renal cell carcinoma. J. Urol.1990; 143: 191. Link, Google Scholar 116 : Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma. Cancer Res.1989; 49: 6972. part 1. Google Scholar 117 : Metanephric transforming growth factor-beta 1 regulates nephrogenesis in vitro. Amer. J. Physiol.1993; 264: F996. part 2. Google Scholar 118 : Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature1985; 313: 228. Google Scholar 119 : Modulation of pro-epidermal growth factor, pro-transforming growth factor alpha and epidermal growth factor receptor gene expression in human renal carcinomas. Cancer Res.1990; 590: 3934. Google Scholar 120 : Transforming growth factor-beta modulates the parathyroid hormone-related protein-induced responses in renal epithelial cells. Endocrinology1993; 133: 145. Google Scholar 121 : Transforming growth factor-beta is a renin secretagogue at picomolar concentrations. Amer. J. Physiol.1993; 265: F537. part 2. Google Scholar 122 : A study of growth factors in human renal cysts with or without renal cell carcinoma. Clin. Chim. Acta1993; 217: 199. Google Scholar 123 : Expression of differentiation antigens and growth-related genes in normal kidney, autosomal dominant polycystic kidney disease, and renal cell carcinoma. Amer. J. Kidney Dis.1992; 19: 22. Google Scholar 124 : Growth regulation of human renal carcinoma cells: role of transforming growth factor alpha. Cancer Res.1992; 52: 3335. Google Scholar 125 : Detection of tumor angiogenesis factor in adenocarcinoma of the kidney. Urology1986; 27: 447. Google Scholar 126 : Analysis of papillary adenocarcinoma. Urology1987; 30: 529. Google Scholar 127 : Influence of growth factors on in vitro invasiveness and type IV collagenolysis of human renal cell carcinoma cells. J. Urol.1994; 151: 223. Abstract, Google Scholar 128 : Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases. Cancer1976; 38: 2469. Google Scholar 129 : Differential expression of mRNAs transforming growth factor beta 1 and beta 3 and c-fos in human normal prostate, benign prostatic hyperplasia and prostatic cancer. J. Urol.1993; 149: 472A. part 2, abstract 1038. Google Scholar 130 : Quantitative determination of transforming growth factor-beta in serum and urine of patients with bladder cancer and its expression in malignant and non-malignant primary epithelial cells. Proc. Amer. Ass. Cancer Res.1994; 35: 44. abstract. Google Scholar 131 : Alpha-interferon down-regulates epidermal growth factor receptors on renal carcinoma cells: relation to cellular responsiveness to the antiproliferative action of alpha-interferon. Cancer Res.1991; 51: 5881. Google Scholar 132 : Evidence for an equilibrium intermediate in the folding-unfolding pathway of a transforming growth factor-alpha-Pseudomonas exotoxin hybrid protein. Biochemistry1994; 33: 2620. Google Scholar 133 : Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstain, produced by MH435-hF3. J. Antibiot.1986; 39: 170. Google Scholar 134 : Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors. Science1988; 242: 933. Google Scholar 135 : Suramin: a novel antineoplastic agent with multiple potential mechanisms of action. Cancer Res.1993; 53: 2239. Google Scholar 136 : Suramin, an active drug for prostate cancer: interim observations in a phase I trial. J. Natl. Cancer Inst.1993; 85: 611. Google Scholar 137 : Recombinant human EGF (rhEGF) enhances the sensitivity of a broad spectrum of human cancer cells to cisplatin. Proc. Amer. Ass. Cancer Res.1994; 35: 321. abstract. Google Scholar 138 : Therapeutic manipulation of cytokines: transforming growth factor beta-1 protects mice treated with lethal doses of cytarabine. Amer. Surg.1994; 60: 18. Google Scholar 139 : Growth factor deprivation therapy utilizing antisense oligonucleotides in the treatment of PC-3 and LNCaP tumors growing in athymic nude mice. Soc. Basic Urol. Res.1994; 8: 48. abstract. Google Scholar Departments of Urology, Cell Biology and Pathology, Vanderbilt University Medical Center, Nashville, Tennessee.© 1995 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byNAUGHTON M, PICUS J, ZHU X, CATALONA W, VOLLMER R and HUMPHREY P (2018) SCATTER FACTOR-HEPATOCYTE GROWTH FACTOR ELEVATION IN THE SERUM OF PATIENTS WITH PROSTATE CANCERJournal of Urology, VOL. 165, NO. 4, (1325-1328), Online publication date: 1-Apr-2001.KUE P and DAAKA Y (2018) ESSENTIAL ROLE FOR G PROTEINS IN PROSTATE CANCER CELL GROWTH AND SIGNALINGJournal of Urology, VOL. 164, NO. 6, (2162-2167), Online publication date: 1-Dec-2000.HABERSTROH K, KAEFER M and BIZIOS R (2018) INHIBITION OF PRESSURE INDUCED BLADDER SMOOTH MUSCLE CELL HYPERPLASIA USING CRM197Journal of Urology, VOL. 164, NO. 4, (1329-1333), Online publication date: 1-Oct-2000.HABERSTROH K, KAEFER M, RETIK A, FREEMAN M and BIZIOS R (2018) THE EFFECTS OF SUSTAINED HYDROSTATIC PRESSURE ON SELECT BLADDER SMOOTH MUSCLE CELL FUNCTIONSJournal of Urology, VOL. 162, NO. 6, (2114-2118), Online publication date: 1-Dec-1999.BISIGNANI G, MCLAUGHLIN P, ORDILLE M, M and I (2018) CELL CANCER IN GROWTH of Urology, VOL. 162, NO. 6, Online publication date: G, M, and (2018) OF IN PROSTATE CANCERJournal of Urology, VOL. 162, NO. 4, Online publication date: and M (2018) OF GROWTH AND GROWTH PROSTATE of Urology, VOL. 162, NO. 2, Online publication date: J, and R (2018) THE OF GROWTH FACTOR IN AND AND of Urology, VOL. NO. 6, Online publication date: K, J, and (2018) CELL IN HYPERPLASIA AND PROSTATE IN FOR of Urology, VOL. NO. 2, Online publication date: and (2018) of on Prostatic of Urology, VOL. NO. 6, Online publication date: M, A, and P (2018) and of Benign Prostatic of Urology, VOL. NO. Online publication date: 1995 by American Urological Association, Mitchell S. Steiner for of Urology, Vanderbilt University Medical Center, Medical Nashville, by All